PMBS .0002 to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line. http://finance.yahoo.com/news/puramed-bioscience-develops-cannabis-based-180000630.html